Skip to content

A study of chemokines in relation to Hashimoto's thyroiditis

Relationship of serum chemokine CCL21 to thyroid function and antibodies in Hashimoto's thyroiditis and potential association with prognosis of Hashimoto's thyroiditis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091273
Enrollment
Unknown
Registered
2024-10-24
Start date
2024-10-25
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto thyroiditis

Interventions

Healthy control group:none

Sponsors

Huai'an Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Hashimoto's thyroiditis: 1) age 18-75 years old; 2) any gender; 3) referring to the diagnostic criteria listed in the 2008 Chinese Guidelines for Diagnosis and Treatment of Thyroid Diseases, thyroid ultrasound suggests diffuse thyroid enlargement with uneven echogenicity and toughened texture, especially with isthmus conus lobe enlargement, and positive serum TgAb and/or TPOAb. Healthy control group: 1) aged 18-75 years; 2) normal thyroid function and antibodies, no diffuse/unevenly echogenic changes on thyroid ultrasound; 3) no autoimmune diseases, malignant tumours, acute or chronic diseases of the liver, kidneys or heart.

Exclusion criteria

Exclusion criteria: 1) other thyroid diseases, such as Graves' disease and subacute thyroiditis; 2) severe cardiopulmonary, hepatic, and renal insufficiency and malignant tumours; 3) severe stress such as acute stroke and acute myocardial infarction in the last 6 months; 4) in pregnancy and lactation; 5) lack of critical laboratory data;.

Design outcomes

Primary

MeasureTime frame
CCL21(C-C motif ligand 21);

Secondary

MeasureTime frame
thyroid stimulating hormone;free thyroxine;Free triiodothyronine;Thyroid Peroxidase Antibodies;Thyroglobulin Antibodies;

Countries

China

Contacts

Public ContactFeng Bai

Huai'an Second People's Hospital

jiefu6887579@163.com+86 134 2018 2598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026